Background Accurate estimates of long-term mortality following tuberculosis treatment are
scarce. This systematic review and meta-analysis aimed to estimate the post-treatment …

The link between chronic kidney disease (CKD) and tuberculosis (TB) has been known for
more than 40 years, but the interaction between these 2 diseases is still poorly understood. …

Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common
form of drug resistance, and is associated with failure, relapse, and acquired rifampicin …

The risk of tuberculosis (TB) is variable among individuals with latent Mycobacterium
tuberculosis infection (LTBI), but validated estimates of personalized risk are lacking. In pooled …

Introduction The emerging epidemiological evidence of increased cardiovascular disease (CVD)
risk among persons diagnosed with tuberculosis (TB) has not been systematically …

Background Relapse continues to place significant burden on patients and tuberculosis (TB)
programmes worldwide. We aimed to determine clinical and microbiological factors …

Background Latent tuberculosis infection (LTBI) screening and treatment is a key component
of the World Health Organization (WHO) EndTB Strategy, but the impact of LTBI screening …

There is limited high-quality evidence available to inform the use of text messaging to
improve latent tuberculosis infection (LTBI) treatment adherence. We performed a parallel, …

BACKGROUND: Canadian tuberculosis (TB) guidelines recommend targeting postlanding
screening for and treatment of latent tuberculosis infection (LTBI) in people migrating to …

Background Despite data suggesting elevated morbidity and mortality among people who
have survived tuberculosis disease, the impact of respiratory tuberculosis on healthcare …